Daniel Bravo Andreu Private Foundation awards a grant to Carles Diez to continue cutting-edge research in cardiology

The Daniel Bravo Andreu Private Foundation has awarded its grants for biomedical research stays at benchmark centres abroad to PhD candidate Carles Diez of Bellvitge University Hospital–Bellvitge Biomedical Research Institute (IDIBELL)

The solidarity campaign “Elles contra l’ELA” kicks off

The “Elles contra ELA” solidarity campaign begins today with the aim of raising awareness about ALS and raising funds for research. This project is promoted by the research group on neurological and neurogenetic diseases of the Bellvitge Biomedical Research Institute (IDIBELL), with the support of the Catalan Foundation of ALS Miquel Valls, the sponsorship of …

The solidarity campaign “Elles contra l’ELA” kicks off Read More »

Begins the exchange program between IDIBELL and SZBL

It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.

SARS-CoV-2 vaccines are safe and effective in people with immunodeficiency

The analysis show that these vaccines are safe and able to generate immunity in three out of four patients with immune system defects from birth, and in almost all patients treated with immunosuppressants who were evaluated in the study.

Psychosocial factors determine the effectiveness of self-care in patients with heart failure

Lack of family and social support and depressive symptoms are the main factors that impair patients’ ability to adopt healthy habits and practices.

Scroll to Top